Someya M, Tokita S, Kanaseki T, Kitagawa M, et al. Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer. Cancer Sci 2022 Sep 7. doi: 10.1111/cas.15566.
PMID: 36069051